ExploreWatchlistsPricing
  1. JP-listed companies
  2. TSUMURA & CO.
  3. Financials
  4. Total non-current liabilities

TSUMURA & CO. (4540)

Market cap
¥288.8B
P/E ratio
11.8x
Tsumura manufactures prescription and over-the-counter medicines, specializing in herbal extract powders and raw medicinal herbs across Japan, China, Laos, and the US.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal non-current liabilities (Million JPY)YoY (%)
Mar 31, 202572,357+12.47%
Mar 31, 202464,332-16.84%
Mar 31, 202377,361+64.61%
Mar 31, 202246,996+25.28%
Mar 31, 202137,513-24.24%
Mar 31, 202049,516+3.46%
Mar 31, 201947,861-1.12%
Mar 31, 201848,402+47.90%
Mar 31, 201732,727+41.90%
Mar 31, 201623,063-1.18%
Mar 31, 201523,339

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat